Tumapon, Baby Boy -.
HRN: 23-76-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFTAZIDIME 1GM (VIAL)
09/29/2023
10/05/2023
IV
96mg
Q12h
Potentially Septic Newborn
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes